Entrepreneur Jeremy Shane joins host Ross Katz to discuss Life for Health, a revolutionary framework aiming to tackle chronic disease through the integration of life insurance, longitudinal data, and preventative care. 

From drug discovery feedback loops to outcomes-based pricing, Shane outlines a bold new path for biotech and healthcare convergence.

​​What You'll Learn in This Episode:

• Why today's healthcare system fails chronic disease patients and how Life for Health aims to fix it.
• How longitudinal data and life insurance can realign healthcare incentives for better outcomes.
• The economic logic behind outcomes-based annuity pricing for breakthrough drugs like GLP-1s.
• What biotech companies gain from a proactive, participant-driven health model.
• How clinical trials could transform through pre-qualified data-rich populations.

Meet Our Guest

Jeremy Shane, Venture Partner at NextGen Venture Partners, is a healthcare innovator focused on chronic disease. With leadership experience at HealthCentral, WebMD, and 2U, he now pioneers Life for Health, blending life insurance with preventative care to realign incentives and extend health span.

Life for Health, the book, will be released in July 2025. 

To learn more about Life For Health or get involved, go to www.lifeforhealth.com

About The Host

Ross Katz is Principal and Data Science Lead at CorrDyn. Ross specializes in building intelligent data systems that empower biotech and healthcare organizations to extract insights and drive innovation.

Connect with Our Guest:

• Sponsor: CorrDyn, a data consultancy
• Connect with Jeremy Shane on LinkedIn or on Twitter @jeremylshane

Connect with Us:

• Follow the podcast for more insightful discussions on the latest in biotech and data science.
• Subscribe and leave a review if you enjoyed this episode!

Sponsored by…

This episode is brought to you by CorrDyn, the leader in data-driven solutions for biotech and healthcare. Discover how CorrDyn is helping organizations turn data into breakthroughs at CorrDyn.